Qihan Biotech
qihanbio.com
Actively hiring
Cell & Gene Therapy
Biotechnology
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
2
Alta Partners, ARCH Venture Partners
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2017
Founded
Backed byfrom the funds' portfolios and accelerator catalogs
Alta Partners 
ARCH Venture Partners Similar startupsby what they do, their industry and backers
Metagenomi is an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for…
Aegle Therapeutics is a pioneer in regenerative medicine developing extracellular vesicle (EV) therapy to meaningfully improve the lives of…
At Ncardia, we are pioneers in iPSC technology providing high-quality cells, relevant screening assays and robust iPSC differentiation…
Kytopen is accelerating access to the next generation of cell therapies through scalable genome engineering by solving manufacturing…
Discover GC Therapeutics, a pioneer in scalable, cutting-edge cell therapies designed to revolutionize treatment across a broad range of…
High science that delivers.. Developing in vivo gene editing therapeutics to transform patient lives.
Overview
Co-founded in 2017 by two pioneers in genome editing technology, Qihan Biotech has world-leading capabilities in multiplexable genome editing as well as vast experience in Immune shielding.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Hangzhou
China
Regional office
Home
5th Floor, Building B, Chuanhuakechuang Mansion, Xiaoshan Innovation Polis, Xiaoshan District, Hangzhou 311200 China.